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Abstract
Chronic recurrent multifocal osteomyelitis (CRMO) is an auto-
inflammatory bone disease of unknown etiology, most commonly 
affecting the metaphysis of long bones, especially the tibia, femur 
and clavicle. The clinical spectrum varies from self-limited uni-or 
multi-focal lesions to chronic recurrent courses. Diagnosis is based 
on clinical, radiologic and pathological findings, is probably under-
diagnosed due to poor recognition of the disease. A dysregulated 
innate immunity causes immune cell infiltration of the bones with 
subsequent osteoclast activation leading to sterile bone lesions. The 
molecular pathophyiology is still incompletely understood but as-
sociation with other auto-inflammatory diseases such as inflamma-
tory bowel disease (IBD), psoriasis, Wegener’s disease, arthritis 
and synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) 
syndrome is interesting. CRMO can precede the symptoms of the 
associated disease by several years. The bone remodeling caused by 
CRMO can cause permanent disability. We report the case of a 
10-year-old boy with CRMO in association with Crohn’s disease. 
(Acta gastro enterol. belg., 2015, 78, 000-000).
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Introduction
Giedion described chronic recurrent multifocal osteo-
myelitis (CRMO) as “an unusual form of multifocal bone 
lesions with subacute and chronic symmetrical osteo-
myelitis” in 1972 (1). Kahn reported the association of 
CRMO with inflammatory bowel disease (2). This non-
infectious autoinflammatory disease of the skeleton 
 affects predominantly children and adolescents but often 
remains a diagnosis by exclusion.
Patients are affected by recurrent episodes of osteo-
myelitis. Laboratory results demonstrate elevated eryth-
rocyte sedimentation rate (ESR) and C-reactive protein 
(CRP), with sterile blood cultures. Lesions can be visual-
ized using radiography or bone scintigraphy (3) but 
whole body magnetic resonance imaging (MRI) increas-
es the number of lesions detected (4). Empiric antibiotic 
therapy does not improve the clinical picture. Although 
the majority of children with CRMO improve with non-
steroidal analgesics or short courses of steroids, a 
 protracted course lasting several years, which can lead to 
permanent deformations, is typical. CRMO can precede 
the symptoms of other auto-inflammatory diseases such 
as inflammatory bowel disease, therefore physicians fol-
lowing these patients should be attentive for new symp-
toms during the disease evolution in order to detect other 
associated auto-inflammatory diseases.
Case report
A 10 year-old boy, presented with a painful left foot 
and low-grade fever of 1 month duration, without a 
 history of trauma, tick bite or foreign travel. There was 
no calor, rubor or tumor and radiography as well as ultra-
sound were normal. Pain persisted despite immobiliza-
tion. Magnetic Resonance Imaging (MRI) of the ankle 
showed bone edema of the left malleolus lateralis sug-
gestive of osteomyelitis. Blood test showed a normal 
blood count, a CRP of 13.8 mg/L (normal, 0-10 mg/L), 
and an ESR of 74 mm/hour (normal, 0-13 mm/h). The 
boy was hospitalized for intravenous antibiotic treatment 
(flucloxacillin) and intermittent nonsteroidal anti- 
inflammatory drugs (NSAID). Blood cultures remained 
negative. Meanwhile, the clinical picture expanded with 
right hip and knee pain, anorexia, weight loss, and inter-
mittent vomiting and bloody diarrhea. Repeat MRI 
showed persisting edema of the left lateral maleolus, the 
distal epiphysis of the right knee and the metadiaphysis 
of the right femur. Bone biopsy showed no evidence of 
malignancy or suppurative infection. Additional bone 
marrow aspirate was normal. Antibiotic switch to ceftri-
axone was unsuccessful and the boy was transferred to 
our clinic. He had lost 20% of his original weight, his 
body mass index (BMI) was -3.8 SD and he displayed 
complete oral food intolerance with persisting vomiting 
and diarrhea. The bone pain was less profound at that 
time but fever persisted. Stool samples revealed toxine 
positive  Clostridium difficile, which was treated with 
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raise the suspicion. Infectious osteomyelitis and malig-
nancy are the most important components of the differen-
tial diagnosis. Laboratory and histopathological findings 
are nonspecific although mildly elevated acute phase 
markers are usually present.
Although plain radiography can reveal osteolytic le-
sions with surrounding sclerosis, whole body MRI can 
reveal more lesions (4). The study of Falip et al. de-
scribes false negative plain radiographs in 39% of cases. 
Bone scintigraphy is able to show the multifocal localiza-
tion but has difficulties discerning physiological metaph-
yseal uptake from disease lesions. Whole body MRI 
therefore is not only able to reveal more extensive 
 inflammation, but also subclinical lesions as well as 
 metaphyseal lesions. This results in a disclosure of a mul-
tifocal involvement in 80% of cases (4). Falin et al. pro-
pose a diagnostic strategy where whole body MRI with 
short tau inversion recovery (STIR) is used, early in the 
diagnostic workout.
CRMO is probably not a single disease but a sign 
compatible with different diagnoses. The pathology is 
not completely understood but since symptoms appear by 
seemingly unprovoked inflammation without auto- 
reactive T cells or auto-antibodies, it is classified as an 
autoinflammatory disorder. A disturbed regulation of the 
innate immunity by cytokine imbalances will cause 
 immune cell infiltration, activation of the osteoclasts and 
osteolysis and bone remodeling as a result (5). Inherited 
forms as in Majeed Syndrome (6) or interleukin-1 recep-
tor antagonist deficiency (7) are monogenic. There is, 
however, also a sporadic type, which is associated with 
several inflammatory disorders such as inflammatory 
bowel disease and psoriasis. Although no definite disease 
causing mutations have been identified in this context, 
the increased incidence of CRMO and other inflamma-
tory disease in first-degree relatives of patients with 
CRMO pleads for a significant genetic contribution (8,9). 
For the clinician it is important to remember that CRMO 
metronidazole without effect on the overall clinical 
 picture.
The aseptic bone lesions unresponsive to antibiotic 
treatment associated with symptoms suggestive of IBD 
led to endoscopic examination. Upper endoscopy re-
vealed important bulbar erosions (Fig. 1A) with a narrow 
pylorus and colonoscopy was limited due to the severity 
of the ulcerations to a left colonoscopy (Fig. 1B). Histol-
ogy confirmed chronic active granulomatous inflamma-
tion of the bulbus and colon, suggestive for Crohn’s dis-
ease. Due to the severity of the picture the patient was 
started on a combined therapy of exclusive enteral feed-
ing (Modulen®) and prednisolone (2 mg/kg/d). Resolu-
tion of gastrointestinal symptoms, fever as well as the 
bone pain was seen within days. Azathioprin (2 mg/kg/d) 
was associated while tapering the steroid therapy. How-
ever, bone symptoms as well as diarrhea reappeared 
while still receiving 1,6 mg/kg/d prednisolone. Stools 
were negative for Clostridium difficile. Infliximab (5 mg/
kg) was started with a classical induction scheme (0, 2, 
6 weeks) followed by maintenance therapy every 
8 weeks. The association of Infliximab allowed to taper 
and stop the steroids and the boy continued this treatment 
regimen (Infliximab and azathioprine) without experi-
encing any relapses for one year.
Discussion
The diagnosis of CRMO starts with a high level of 
clinical awareness based upon night bone pain eventually 
associated with low-grade fever and sometimes swelling 
and warmth over the affected area. The multiple bone le-
sions diagnosed clinically and/or using imaging have a 
prolonged and fluctuating course of recurrent episodes in 
atypical infectious osteomyelitis sites. Most are localized 
in the metaphysis of the long bones, the clavicula, spine 
and mandibula. The absence of microorganisms as well 
as the unresponsiveness to antibiotic treatment should 
Fig. 1. — Endoscopic view of the bulbus and colon of the patient revealing erosions and ulcerations.
A B
A case of Chronic Recurrent Multifocal Osteomyelitis 3
Acta Gastro-Enterologica Belgica, Vol. LXXVIII, April-June 2015
reported to improve symptoms in the majority of pa-
tients (23). It is postulated that blocking of the cyclooxy-
genase pathway will inhibit the prostaglandin synthesis 
and therefore decrease the bone lesions (23). In case of 
treatment failure with NSAID, steroids have been tried, 
however, relapses can be expected when steroids are 
 tapered (24). Biphosphonates were used with success in 
some cases where NSAIDs caused insufficient pain 
symptoms often precede the symptoms of inflammatory 
bowel disease (IBD), as was the case in our patient (10). 
Table 1 gives an overview of all reported patients with 
both CRMO and IBD (10-21). CRMO is not an innocent 
problem as potentially permanent deformities can occur 
as result of bone remodeling of vertebral fractures (22).
There are no placebo-controlled studies available for 
the treatment of CRMO. Different NSAIDs have been 
Table 1. — Overview of all reported cases of chronic recurrent multifocal osteomyelitis (CRMO) associated with inflamma-
tory bowel disease (IBD)
Reference N Sex IBD Age (yr) Presenting 
picture
Time to 
diagnosis (m) 
(time with 
combined 
complaints)
Time (m) 
between 
2 clinical 
pictures
Treatment CRMO Treatment IBD
von Kalle (21) 1 CD
Kim (20) 1 M UC 41 IBD 1 8 NSAID, Steroids, 
Pamidronate, MTX
ASA, Colectomy
Morbach (19) 1 M CD 12 CRMO & IBD 1 (1)
1 F UC 15 CRMO & IBD 6 (1)
1 M CD 15 CRMO 36 36
1 F CD 10 CRMO 3 5
Jansson (17) 5 2 CD
3UC
Girschick (18) 1 F CD 9 CRMO 4 15 NSAID, ASA, 
steroids, corset
Steroids, ASA, 
Azathioprine
E. Carpenter (f) 1 F CD 9 CRMO 5 19 NSAID Steroids, 
Metronidazole, 
6-MP, Azathioprine, 
Infliximab
Schilling (15) 1 F CD 53 CRMO 1 48 NSAID ASA
1 M CD 33 CRMO NSAID ASA
1 F UC 38 CRMO 180 NSAID ASA
1 F CD 20 CRMO 48 NSAID ASA, Steroids
1 F CD 9 CRMO 48 NSAID, steroids, 
calcitonin
ASA, Steroids, MTX, 
Azithromycin
Huber (14) 3
Bazrafshan (13) 1 F CU 12 CRMO 24 NSAID ASA, Steroids, 
Colectomy
Bousvaros (10) 1 F CD 10 CRMO 60 Steroids Sulfasalazine
1 M CD 8 CRMO 36 60 Steroids, ASA
1 F CD 8 CRMO 36 3 NSAID Steroids, ASA
1 F CD 13 CRMO 6 Steroids, Azathioprine
1 M CD 10 CRMO 36 NSAID Steroids, ASA
1 F CD 10 CRMO 18 Steroids, ASA, MTX
Bognar (11) 1 M CD 43 CRMO & IBD 0,1 (0,1) NSAID Steroids, ASA
Omidi (12) 1 F UC 12 CRMO 36 5 Steroids
TOTAL 30 14F/7M 8 UC/
19 MC
12 (8-53) IBD first 1
CRMO first 17
Comined 3
5 (0,1-36) 19 (3-180)
Reference gives first author and reference list number, number of cases reported, gender: F female, M male, Type of IBD diagnosed: CD Crohn’s 
disease, UC ulcerative colitis, Age at diagnosis in years (yr), presenting clinical picture, duration of symptoms before diagnosis in months (m), time 
gap between the 2 diagnoses in months, treatment for CRMO and IBD: ASA aminosalicilates, MTX methotrexate, 6-MP 6-mercaptopurine, Steroids 
corticosteroids, NSAID non-steroidal anti-inflammatory drugs.
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 control, although the mechanism of action remains un-
known (25). Infliximab, a chimeric monoclonal antibody 
against tumour necrosis factor alfa, has been reported 
successful in a minority of very resistant patients (26). 
However, probably patients with associated Crohn’s dis-
ease will respond better, as is the case in our patient with 
a complete disease control of more than 1 year (16). 
 Controlling the Crohn’s disease will improve the bone 
symptoms in most of these patients, as was the case in 
our patient (10).
Conclusion
CRMO is a clinical entity, which needs a high degree 
of suspicion for its diagnosis. It can be a first sign of  other 
underlying diseases, demanding persistent awareness of 
the physician. Treatment is mandatory as it can cause 
permanent bone alterations, but most patients will re-
spond to NSAIDs.
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